BIEL News! BioElectronics' ActiPatch® Therapy
Post# of 106844
(Total Views: 172)
Posted On: 11/06/2020 12:07:27 PM
BIEL News!
BioElectronics' ActiPatch® Therapy To Be Marketed By DonJoy® Advantage
Drug-Free Pain Relief Technology with Premium Wraps
PR Newswire
FREDERICK, Md., Nov. 6, 2020
FREDERICK, Md., Nov. 6, 2020 /PRNewswire/ -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce the execution of a commercial partnership agreement with Scott Specialties Inc (SS http://scottspecialties.com/) to bring their innovative pain management devices to the retail consumer healthcare marketplace under the DonJoy® (DJO www.djoglobal.com) Advantage product line.
This commercial partnership will leverage the ActiPatch's broad indications for use and offer an active-passive treatment combination product to treat pain, increase physical functionality and improve overall quality of life. The new products will be marketed under DJO's DonJoy Advantage (DJA) line of orthopedic appliances and sold as an EME Knee Wrap and an EME Back Wrap," powered by ActiPatch". In January 2020, BioElectronics obtained a 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the drug free ActiPatch® medical device, for the indication: "adjunctive treatment of musculoskeletal pain." With the latest clearance, ActiPatch remains the only pulsed shortwave therapy (PSWT) device with an over-the-counter clearance for treating any form of musculoskeletal pain.
Keith Nalepka, VP Sales and Marketing for BioElectronics expressed his enthusiasm for the market opportunity: "This is a great opportunity for the ActiPatch brand. We have executed on our OEM strategy by partnering with Scott Specialties this past spring and leveraging their relationship with DJO to drive ActiPatch sales. During the pandemic we have seen consumers continuing to seek alternatives to oral medicines for pain. By partnering with Scott Specialties and another soon-to-be-announced, major sports medicine company, we are confident that these innovative product offerings will meet the need for a growing demand."
Kelly Whelan, President of BioElectronics, stated "We are thrilled to have the marketing strength of DonJoy Advantage coupled with the power of ActiPatch in products available to consumers online now at www.donjoyperformance.com. A soft launch in retail outlets is scheduled for December and the products will be promoted by DJO's sales force in Q1, 2021."
About BioElectronics Corporation
BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; Allay® Menstrual Pain Therapy.
BioElectronics' ActiPatch® Therapy To Be Marketed By DonJoy® Advantage
Drug-Free Pain Relief Technology with Premium Wraps
PR Newswire
FREDERICK, Md., Nov. 6, 2020
FREDERICK, Md., Nov. 6, 2020 /PRNewswire/ -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce the execution of a commercial partnership agreement with Scott Specialties Inc (SS http://scottspecialties.com/) to bring their innovative pain management devices to the retail consumer healthcare marketplace under the DonJoy® (DJO www.djoglobal.com) Advantage product line.
This commercial partnership will leverage the ActiPatch's broad indications for use and offer an active-passive treatment combination product to treat pain, increase physical functionality and improve overall quality of life. The new products will be marketed under DJO's DonJoy Advantage (DJA) line of orthopedic appliances and sold as an EME Knee Wrap and an EME Back Wrap," powered by ActiPatch". In January 2020, BioElectronics obtained a 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the drug free ActiPatch® medical device, for the indication: "adjunctive treatment of musculoskeletal pain." With the latest clearance, ActiPatch remains the only pulsed shortwave therapy (PSWT) device with an over-the-counter clearance for treating any form of musculoskeletal pain.
Keith Nalepka, VP Sales and Marketing for BioElectronics expressed his enthusiasm for the market opportunity: "This is a great opportunity for the ActiPatch brand. We have executed on our OEM strategy by partnering with Scott Specialties this past spring and leveraging their relationship with DJO to drive ActiPatch sales. During the pandemic we have seen consumers continuing to seek alternatives to oral medicines for pain. By partnering with Scott Specialties and another soon-to-be-announced, major sports medicine company, we are confident that these innovative product offerings will meet the need for a growing demand."
Kelly Whelan, President of BioElectronics, stated "We are thrilled to have the marketing strength of DonJoy Advantage coupled with the power of ActiPatch in products available to consumers online now at www.donjoyperformance.com. A soft launch in retail outlets is scheduled for December and the products will be promoted by DJO's sales force in Q1, 2021."
About BioElectronics Corporation
BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; Allay® Menstrual Pain Therapy.
(0)
(0)